Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Curr Oncol. 2021 Jan 25;28(1):693-701. doi: 10.3390/curroncol28010068.
This study investigates whether minimally invasive esophagectomy (MIE) is a safe and effective way for patients with resectable esophageal cancer by comparing the short-term quality of life (QOL) after minimally invasive esophagectomy and open esophagectomy (OE). A total number of 104 patients who underwent esophagectomy from January 2013 to March 2014 were enrolled in this study. These patients were divided into two groups (MIE and OE group). Three scoring scales of quality of life were used to evaluate QOL before the operation and at the first, third, sixth and twelfth months after MIE or OE, which consist of Karnofshy performance scale (KPS), the European Organization for Research and Treatment questionnaire QLQC-30 (EORTC QLQC-30) and esophageal cancer supplement scale (OES-18). The MIE group was higher than the OE group in one-year survival rate (92.54% vs. 72.00%). Significant differences between the two groups were observed in intraoperative bleeding volume (158.53 ± 91.07 mL vs. 228.97 ± 109.33 mL, = 0.001), and the incidence of postoperative pneumonia (33.33% vs. 58.62%, = 0.018). The KPS of MIE group was significantly higher than the OE group at the first (80 vs. 70, = 0.004 < 0.05), third (90 vs. 80, = 0.006 < 0.05), sixth (90 vs. 80, = 0.007 < 0.05) and twelfth months (90 vs. 80, = 0.004 < 0.05) after surgery. The QLQC-30 score of MIE group was better than OE group at first and twelfth months after the operation. The OES-18 score of MIE group was significantly better than OE group at first, sixth and twelfth months after surgery. The short-term quality of life in MIE group was better than OE group.
本研究通过比较微创食管切除术(MIE)和开放食管切除术(OE)治疗可切除食管癌患者的短期生活质量(QOL),探讨 MIE 是否是一种安全有效的方法。本研究共纳入 2013 年 1 月至 2014 年 3 月期间接受食管切除术的 104 例患者。这些患者被分为两组(MIE 组和 OE 组)。使用三种生活质量评分量表在手术前和 MIE 或 OE 后第 1、3、6 和 12 个月评估 QOL,包括 Karnofshy 体能状态评分(KPS)、欧洲癌症研究与治疗组织问卷 QLQ-C30(EORTC QLQ-C30)和食管癌补充量表(OES-18)。MIE 组的 1 年生存率(92.54% vs. 72.00%)高于 OE 组。两组间术中出血量(158.53 ± 91.07 mL vs. 228.97 ± 109.33 mL, = 0.001)和术后肺炎发生率(33.33% vs. 58.62%, = 0.018)差异有统计学意义。MIE 组的 KPS 在术后第 1、3、6 和 12 个月时均显著高于 OE 组(80 分 vs. 70 分, = 0.004 < 0.05)。MIE 组在术后第 1、3、6 和 12 个月时的 QLQ-C30 评分均优于 OE 组。MIE 组在术后第 1、6 和 12 个月时的 OES-18 评分显著优于 OE 组。MIE 组的短期生活质量优于 OE 组。